We are live on ! Find out more
DALS

DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS

Delisted

DALS was delisted on the 28th of July, 2023.

Back to rankings

44 hedge funds and large institutions have $150M invested in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 7

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

22% more funds holding

Funds holding: 36 → 44 (+8)

7% less capital invested

Capital invested by funds: $162M → $150M (-$11.1M)

Holders
44
Holders Change
+8
Holders Change %
+22.22%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
8
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Saba Capital Management
New York
+$10.8M
2
Marshall Wace
Marshall Wace
United Kingdom
+$4.76M
3
SC
Sculptor Capital
New York
+$4.6M
4
LA
Linden Advisors
New York
+$3.68M
5
RIA
RP Investment Advisors
Ontario, Canada
+$3.42M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$28.1M
2
DCM
Driehaus Capital Management
Illinois
-$9.81M
3
HP
Hound Partners
New York
-$7.36M
4
SCM
Soleus Capital Management
Connecticut
-$2.41M
5
FIG
Fortress Investment Group
New York
-$2.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
CL
26
CSS LLC
Illinois
$1.12M +$1.11M +114,922 New
Toronto Dominion Bank
27
Toronto Dominion Bank
Ontario, Canada
$1.08M +$966K +100,000 +917%
SCM
28
Segantii Capital Management
Hong Kong
$975K – – –
SCM
29
Soleus Capital Management
Connecticut
$972K -$2.41M -250,000 -71%
CIM
30
Cowen Investment Management
New York
$972K +$966K +100,000 New
Verition Fund Management
31
Verition Fund Management
Connecticut
$917K +$908K +94,020 New
FTCM
32
Fir Tree Capital Management
New York
$758K +$751K +77,777 New
EAM
33
Exos Asset Management
New York
$748K +$32.9K +3,402 +5%
COPPSERS
34
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$486K +$483K +50,000 New
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$448K +$22.2K +2,300 +5%
PSC
36
Piper Sandler & Co
Minnesota
$244K +$241K +25,003 New
UFM
37
Ursa Fund Management
California
$243K +$241K +25,000 New
Bank of America
38
Bank of America
North Carolina
$242K – – –
SFM
39
Spartan Fund Management
Canada
$181K +$143K +14,824 New
HF
40
HRT Financial
New York
$163K +$162K +16,747 New
PHK
41
Point72 Hong Kong
Hong Kong
$122K – – –
CCMU
42
Cheyne Capital Management (UK)
United Kingdom
$97K – – –
AA
43
Ancora Advisors
Ohio
$6K – – –
UBS Group
44
UBS Group
Switzerland
$2K – – –
Wellington Management Group
45
Wellington Management Group
Massachusetts
– -$28.1M -2,865,991 Closed
DCM
46
Driehaus Capital Management
Illinois
– -$9.81M -1,000,000 Closed
HP
47
Hound Partners
New York
– -$7.36M -750,000 Closed
FIG
48
Fortress Investment Group
New York
– -$2.17M -221,350 Closed
PCM
49
Prelude Capital Management
New York
– -$542K -55,275 Closed
CSS
50
Cubist Systematic Strategies
Connecticut
– -$22K -2,247 Closed
1
2
3

DALS Hedge Fund Activity: Q1 2022 in Review

44 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) for Q1 2022, worth a combined $150M — down 6.9% from $162M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new DALS positions and 7 closed out — a net gain of 8 holders — while 8 added to existing stakes and 5 trimmed.

The largest buyer was Saba Capital Management, opening a new position worth an estimated $10.8M. The largest seller was Wellington Management Group, exiting entirely with an estimated $28.1M sold.

  • 44 institutional investors held DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) as of Q1 2022, up from 36 in Q4 2021.
  • Funds reported $150M of DA32 Life Science Tech Acquisition Corp. Class A Common Stock stock for Q1 2022, down 6.9% quarter-over-quarter.
  • 15 funds opened new DA32 Life Science Tech Acquisition Corp. Class A Common Stock positions in Q1 2022 and 7 closed out, a net change of +8 holders.
  • The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock buyer in Q1 2022 was Saba Capital Management, an estimated $10.8M added.
  • The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock seller in Q1 2022 was Wellington Management Group, an estimated $28.1M sold.

Based on aggregated 13F filings for Q1 2022.